Director Samueli sells 781,967 shares for $250.0M; stock down 27.2% from 52-week high, 5 prior AVGO sales all well-timed to 90d declines
Henry Samueli executed 16 separate sales totaling 781,967 shares for $250,000,301.60 at blended average price $319.71 on 2026-03-25, reducing his holdings by 2.5%. This occurs as AVGO stock trades 27.2% below its 52-week high of $412.97 and down 9.5% over the prior 30 days. Notably, Samueli's 5 prior sales at AVGO (all on 2025-12-08) showed a 100% well-timed rate at the 90-day mark, with each sale followed by 90-day declines ranging from -17.0% to -18.8%. The current 30-day decline of -9.5% aligns with this pattern, suggesting the insider's trading decisions at this ticker have consistently preceded downward price movements.
Director Henry Samueli sells 320,316 shares of AVGO for $128.3M in 10 transactions at $398–$407; stock at 52-week high
Director Henry Samueli executed 10 separate sales totaling 320,316 shares for $128,297,553.18 on 2025-12-08, with transaction prices ranging from $398.14 to $407.01 and a blended average of $400.53. The current stock price is $406.29, at the top of the 52-week range, and the stock has gained 16.3% in the past 30 days and 9.9% over 90 days. Samueli remains a major shareholder with 37,257,607 shares post-transaction (representing a -0.9% reduction). His prior sales at AVGO on 2025-09-24 showed modest positive returns over 30 days (4.4%–5.8%), though longer-term outcome data is not yet available for those trades. The sale occurs at elevated valuation levels (P/E of 319.91) on a stock near all-time highs, and despite the company's strong fundamentals (annual revenue growth of +44.0% and net income of $4.1B), the insider's disposition of equity at current price levels warrants investor attention.
Director Henry Samueli sells 368,797 shares at blended avg $337.91 for $124.6M on 2025-09-24.
Henry Samueli, a Broadcom director, executed 6 separate sales totaling 368,797 shares for $124,620,221.76 on 2025-09-24, reducing his holdings by 1.0% from 38.02M to 37.65M shares. The sales were executed across a tight price band ($334.59–$339.38), suggesting deliberate execution over the course of a single trading day. His historical timing pattern at Broadcom shows 0 of 5 prior sells were well-timed on a 90-day basis, and his cross-ticker track record yields a 0.00% well-timed rate on sells despite a +37.5% average 90-day return—indicating prior sell decisions have typically been followed by stock appreciation rather than decline. Broadcom's fundamental profile shows elevated multiples (P/E 263.41) against strong operational momentum (+44.0% annual revenue growth, $4.1B net income on $16.0B revenue), with the stock currently at $334.53, representing -9.5% from the 52-week high but +11.4% over 30 days and +24.2% over 90 days.
Director Henry Samueli sells 473,898 shares at avg $265.33 for $125.7M, retains 31.48M shares.
Director Henry Samueli executed 7 separate sales totaling 473,898 shares for $125,737,538.37 on 2025-06-25, reducing his position by 1.5% to 31,479,210 shares. The sales occurred at prices between $264.16 and $269.62, near the stock's 52-week high of $270.17. Notably, his prior 5 trades at AVGO all occurred on 2025-03-26 and generated positive 90-day returns (5.7% to 47.9%), indicating he has consistently sold before the stock appreciated—a poorly-timed pattern for capturing gains. The current trade occurs at levels very close to 52-week highs, but without a 10b5-1 plan flag, the timing relative to the stock's 59.3% 90-day advance and 44.0% revenue growth warrants attention to whether this reflects fundamental reassessment or portfolio decisions at elevated valuations.
Director SAMUELI HENRY sold 663,976 shares for $120,576,862.62 on 2025-03-26 at blended avg $181.60; stock now at $169.12.
SAMUELI HENRY, a Director at Broadcom, executed 11 separate sales totaling 663,976 shares for $120,576,862.62 on 2025-03-26, reducing his holdings from 39.33M to 38.66M shares (-1.7%). The sales spanned prices from $178.36 to $187.79 with a blended average of $181.60. Since the transaction date, the stock has declined to $169.12 (down 32.4% from its 52-week high of $250.00) and has fallen 20.6% over the past 30 days and 30.0% over 90 days. This transaction occurred during a period of significant price weakness; the magnitude of the sale ($120.6M) and the consistent execution across 11 tranches over the filing date suggest programmatic action rather than opportunistic selling into strength.
